ALCLS — Cellectis SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Cellectis SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	297	452	361	268	186
Net Total Accounts Receivable
Net Total Receivables	14.7	22.1	15.3	19.2	31.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	323	488	392	315	225
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.23	10	69.3	146	148
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	333	501	467	469	382
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45.5	46.9	62.6	52	49.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	68	91.5	152	194	161
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	265	409	315	276	221
Total Liabilities & Shareholders' Equity	333	501	467	469	382
Total Common Shares Outstanding

Discover the metrics influencing Cellectis SA's share price